Role of non-receptor tyrosine kinases in epilepsy: significance and potential as therapeutic targets

References

• Shanker OR, Kumar S, Dixit AB, et al. Epigenetics of neurological diseases. Prog Mol Biol Transl Sci. 2023;198:165–184. doi: 10.1016/bs.pmbts.2023.01.006
   PubMedGoogle Scholar
• Dixit AB, Tripathi M, Chandra PS, et al. Molecular biomarkers in drug-resistant epilepsy: facts & possibilities. Int J Surg. 2016 Dec;36:483–491. doi: 10.1016/j.ijsu.2015.08.029
   PubMed Web of Science ®Google Scholar
• Henshall DC, Kobow K. Epigenetics and epilepsy. Cold Spring Harb Perspect Med. 2015 Oct;5(12):a022731. doi: 10.1101/cshperspect.a022731
   PubMed Web of Science ®Google Scholar
• Kumar S, Shanker OR, Banerjee J, et al. Epigenetics in epilepsy. Prog Mol Biol Transl Sci. 2023;198:249–269. doi: 10.1016/bs.pmbts.2023.01.005
   PubMedGoogle Scholar
• Chandra PS, Tripathi M. Epilepsy surgery: recommendations for India. Ann Indian Acad Neurol. 2010;13(2):87–93. doi:10.4103/0972-2327.64625
   PubMed Web of Science ®Google Scholar
• Drug-Resistant Epilepsy | NEJM. [cited 2023 Mar 5]. Available from: https://www.nejm.org/doi/full/10.1056/nejmra1004418
   Google Scholar
• López González FJ, Rodríguez Osorio X, Gil-Nagel Rein A, et al. Epilepsia resistente a fármacos. Concepto y alternativas terapéuticas. Neurología. 2015 Sep;30(7):439–446.
   PubMed Web of Science ®Google Scholar
• Rakhade SN, Jensen FE. Epileptogenesis in the immature brain: emerging mechanisms. Nat Rev Neurol. 2009 Jul;5(7):380–391. doi: 10.1038/nrneurol.2009.80
   PubMed Web of Science ®Google Scholar
• Mechanisms of epileptogenesis and potential treatment targets - PubMed. [cited 2023 Mar 7]. Available from: https://pubmed.ncbi.nlm.nih.gov/21256455/
   Google Scholar
• Temkin NR. Preventing and treating posttraumatic seizures: the human experience. Epilepsia. 2009 Feb;50(Suppl 2):10–13. doi: 10.1111/j.1528-1167.2008.02005.x
   PubMed Web of Science ®Google Scholar
• Meldrum BS, Rogawski MA. Molecular targets for antiepileptic drug development. Neurotherapeutics. 2007 Jan;4(1):18–61. doi: 10.1016/j.nurt.2006.11.010
   PubMed Web of Science ®Google Scholar
• Lasoń W, Dudra-Jastrzębska M, Rejdak K, et al. Basic mechanisms of antiepileptic drugs and their pharmacokinetic/pharmacodynamic interactions: an update. Pharmacol Rep. 2011;63(2):271–292. doi: 10.1016/s1734-1140(11)70497-2
   PubMed Web of Science ®Google Scholar
• Synaptic roles of cyclin-dependent kinase 5 & its implications in epilepsy - PMC. [ Online]. [cited 2023 Feb 6]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501049/
   Google Scholar
• Hanks SK, Hunter T. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification1. Faseb J. 1995;9(8):576–596. doi: 10.1096/fasebj.9.8.7768349
   PubMed Web of Science ®Google Scholar
• Siveen KS, Prabhu KS, Achkar IW, et al. Role of non receptor tyrosine kinases in hematological malignances and its targeting by natural products. Mol cancer. 2018 Feb;17(1):31.
   PubMedGoogle Scholar
• Non-receptor protein tyrosine kinases signaling pathways in normal and cancer cells: critical reviews in clinical laboratory sciences. 2023 Feb 6; 51(3). Available from: https://www.tandfonline.com/doi/abs/10.3109/10408363.2013.874403
   Google Scholar
• Sharma S, Carlson S, Gregory-Flores A, et al. Mechanisms of disease-modifying effect of saracatinib (AZD0530), a Src/Fyn tyrosine kinase inhibitor, in the rat kainate model of temporal lobe epilepsy. Neurobiol Dis. 2021 Aug;156:105410. doi: 10.1016/j.nbd.2021.105410
   PubMed Web of Science ®Google Scholar
• A role for Src kinase in spontaneous epileptiform activity in the CA3 region of the hippocampus | PNAS. 2023 Feb 06. [Online]. doi: 10.1073/pnas.140219097
   Google Scholar
• Hunter T. Tyrosine phosphorylation: thirty years and counting. Curr Opin Cell Biol. 2009 Apr;21(2):140–146. doi: 10.1016/j.ceb.2009.01.028
   PubMed Web of Science ®Google Scholar
• Schlessinger J, Ullrich A. Growth factor signaling by receptor tyrosine kinases. Neuron. 1992 Sep;9(3):383–391. doi: 10.1016/0896-6273(92)90177-f
   PubMed Web of Science ®Google Scholar
• Wiggs CL, Martin A. Properties and mechanisms of perceptual priming. Curr Opin Neurobiol. 1998 Apr;8(2):227–233. doi: 10.1016/s0959-4388(98)80144-x
   PubMed Web of Science ®Google Scholar
• Flanagan JG, Vanderhaeghen P. The ephrins and Eph receptors in neural development. Annu Rev Neurosci. 1998;21(1):309–345. doi: 10.1146/annurev.neuro.21.1.309
   PubMedGoogle Scholar
• Hubbard SR, Till JH. Protein tyrosine kinase structure and function. Annu revi biochem. 2000;69(1):373–398. doi: 10.1146/annurev.biochem.69.1.373
   PubMed Web of Science ®Google Scholar
• Neet K, Hunter T. Vertebrate non-receptor protein-tyrosine kinase families. Genes Cells. 1996 Feb;1(2):147–169. doi: 10.1046/j.1365-2443.1996.d01-234.x
   PubMed Web of Science ®Google Scholar
• Kuriyan J, Cowburn D. Modular peptide recognition domains in eukaryotic signaling. Annu Rev Biophys Biomol Struct. 1997;26(1):259–288. doi: 10.1146/annurev.biophys.26.1.259
   PubMedGoogle Scholar
• Ali DW, Salter MW. NMDA receptor regulation by Src kinase signalling in excitatory synaptic transmission and plasticity. Curr Opin Neurobiol. 2001 Jun;11(3):336–342. doi: 10.1016/s0959-4388(00)00216-6
   PubMed Web of Science ®Google Scholar
• Zhang F, Guo A, Liu C, et al. Phosphorylation and assembly of glutamate receptors after brain ischemia. Stroke. 2013 Jan;44(1):170–176. doi: 10.1161/STROKEAHA.112.667253
   PubMed Web of Science ®Google Scholar
• Kalia LV, Pitcher GM, Pelkey KA, et al. PSD-95 is a negative regulator of the tyrosine kinase Src in the NMDA receptor complex. Embo J. 2006 Oct;25(20):4971–4982. doi: 10.1038/sj.emboj.7601342
   PubMed Web of Science ®Google Scholar
• Moretti A. [Metabolic and neurochemical effects of nicergoline on the central nervous system. A review of the experimental studies (author’s transl)]. Arzneimittelforschung. 1979 Jan;29(8a):1213–1223.
   PubMedGoogle Scholar
• Salter MW, Pitcher GM. Dysregulated Src upregulation of NMDA receptor activity: a common link in chronic pain and schizophrenia. FEBS J. 2012 Jan;279(1):2–11. doi: 10.1111/j.1742-4658.2011.08390.x
   PubMed Web of Science ®Google Scholar
• Zhu J-M, Li K-X, Cao S-X, et al. Increased NRG1-ErbB4 signaling in human symptomatic epilepsy. Sci Rep. 2017 Mar;7(1, Art. no. 1). doi: 10.1038/s41598-017-00207-7
   Google Scholar
• Barki-Harrington L, Elkobi A, Tzabary T, et al. Tyrosine phosphorylation of the 2B subunit of the NMDA receptor is necessary for taste memory formation. J Neurosci. 2009 Jul;29(29):9219–9226. doi: 10.1523/JNEUROSCI.5667-08.2009
   PubMed Web of Science ®Google Scholar
• Jurd R, Tretter V, Walker J, et al. Fyn kinase contributes to tyrosine phosphorylation of the GABAA receptor γ2 subunit. Mol Cell Neurosci. 2010 Jun;44(2):129–134. doi: 10.1016/j.mcn.2010.03.002
   PubMed Web of Science ®Google Scholar
• Full article: Fyn gene silencing reduces oligodendrocytes apoptosis through inhibiting ERK1/2 phosphorylation in epilepsy. 2023 Feb 06. [Online]. doi: 10.1080/21691401.2019.1671428
   Google Scholar
• Role of the Fyn-PKCδ signaling in SE-induced neuroinflammation and epileptogenesis in experimental models of temporal lobe epilepsy - PMC. [ Online]. [cited 2023 Feb 6]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753797/
   Google Scholar
• A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle - PubMed. [ Online]. [cited 2023 Feb 6]. Available from: https://pubmed.ncbi.nlm.nih.gov/8242749/
   Google Scholar
• Focal adhesion kinase in the brain: novel subcellular localization and specific regulation by Fyn tyrosine kinase in mutant mice - PubMed. [ Online]. [cited 2023 Feb 6]. Available from: https://pubmed.ncbi.nlm.nih.gov/7544314/
   Google Scholar
• Focal adhesion molecules regulate astrocyte morphology and glutamate transporters to suppress seizure-like behavior - PMC. [ Online]. [cited 2023 Feb 6]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6217442/
   Google Scholar
• Potential roles of the RGMa-FAK-Ras pathway in hippocampal mossy fiber sprouting in the pentylenetetrazole kindling model. [ Online]. [cited 2023 Feb 6]. Available from: https://doi.org/10.3892/mmr.2014.2993.
   Google Scholar
• Cytoplasmic signalling by the c-Abl tyrosine kinase in normal and cancer cells - PubMed. [ Online]. [cited 2023 Feb 6]. Available from: https://pubmed.ncbi.nlm.nih.gov/18851712/
   Google Scholar
• c-Abl in neurodegenerative disease - PubMed. [ Online]. [cited 2023 Feb 6]. Available from: https://pubmed.ncbi.nlm.nih.gov/21728062/
   Google Scholar
• Altered expression of c-Abl in patients with epilepsy and in a rat model - PubMed. [ Online]. [cited 2023 Feb 6]. Available from: https://pubmed.ncbi.nlm.nih.gov/24623669/
   Google Scholar
• Abl deregulates Cdk5 kinase activity and subcellular localization in Drosophila neurodegeneration | Cell Death & Differentiation. [ Online]. [cited 2023 Feb 6]. Available from: https://www.nature.com/articles/4402033
   Google Scholar
• Differential regulation of excitatory synaptic transmission in the hippocampus and anterior temporal lobe by cyclin dependent kinase 5 (Cdk5) in mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) - PubMed. [ Online]. [cited 2023 Feb 6]. Available from: https://pubmed.ncbi.nlm.nih.gov/34217817/
   Google Scholar
• Perez de Arce K, Varela-Nallar L, Farias O, et al. Synaptic clustering of PSD-95 is regulated by c-Abl through tyrosine phosphorylation. J Neurosci. 2010 Mar;30(10):3728–3738.
   PubMed Web of Science ®Google Scholar
• Singh S, Singh TG. Imatinib attenuates pentylenetetrazole kindled and pilocarpine induced recurrent spontaneous seizures in mice. Neurochem Res. 2023 Feb;48(2):418–434. doi: 10.1007/s11064-022-03758-y
   PubMed Web of Science ®Google Scholar
• Systems biology of JAK-STAT signalling in human malignancies - PubMed. [ Online]. [cited 2023 Feb 6]. Available from: https://pubmed.ncbi.nlm.nih.gov/21762720/
   Google Scholar
• Starr R, Hilton DJ. SOCS: suppressors of cytokine signalling. Int J Biochem Cell Biol. 1998 Oct;30(10):1081–1085. doi: 10.1016/s1357-2725(98)00067-3
   PubMed Web of Science ®Google Scholar
• Nicolas CS, Amici M, Bortolotto ZA, et al. The role of JAKSTAT signaling within the CNS. JAKSTAT. 2013 Jan;2(1):e22925.
   PubMedGoogle Scholar
• Sun H, Ma D, Cheng Y, et al. The JAK-STAT signaling pathway in epilepsy. Curr Neuropharmacol. 2022 Dec. doi: 10.2174/1570159X21666221214170234
   Web of Science ®Google Scholar
• Raible DJ, Frey LC, Brooks-Kayal AR. Effects of JAK2-STAT3 signaling after cerebral insults. JAKSTAT. 2014 Jun;3(2):e29510. doi: 10.4161/jkst.29510
   PubMedGoogle Scholar
• The effect of STAT3 Inhibition on status epilepticus and subsequent spontaneous seizures in the Pilocarpine Model of Acquired Epilepsy - PMC. [Online]. [cited 2023 Feb 6]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3908775/
   Google Scholar
• Li Y-Z, Zhang L, Liu Q, et al. The effect of single nucleotide polymorphisms of STAT3 on epilepsy in children. Eur Rev Med Pharmacol Sci. 2020 Jan;24(2):837–842. doi: 10.26355/eurrev_202001_20067
   PubMed Web of Science ®Google Scholar
• Hixson KM, Cogswell M, Brooks-Kayal AR, et al. Evidence for a non-canonical JAK/STAT signaling pathway in the synthesis of the brain’s major ion channels and neurotransmitter receptors. BMC Genomics. 2019 Aug;20(1):677. doi: 10.1186/s12864-019-6033-2
   PubMed Web of Science ®Google Scholar
• Prieto-Echagüe V, Miller WT. Regulation of ack-family nonreceptor tyrosine kinases. J Signal Transduct. 2011;2011:1–9. doi: 10.1155/2011/742372
   Google Scholar
• Manser E, Leung T, Salihuddin H, et al. A non-receptor tyrosine kinase that inhibits the GTPase activity of p21cdc42. Nature. 1993 May;363(6427):364–367. doi: 10.1038/363364a0
   PubMed Web of Science ®Google Scholar
• Mahajan K, Mahajan NP. ACK1/TNK2 tyrosine kinase: molecular signaling and evolving role in cancers. Oncogene. 2015 Aug;34(32):4162–4167. doi: 10.1038/onc.2014.350
   PubMed Web of Science ®Google Scholar
• Mutations in TNK2 in severe autosomal recessive infantile-onset epilepsy - PMC. [ Online]. [cited 2023 Feb 7]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527160/
   Google Scholar
• The role of seizure-related SEZ6 as a susceptibility gene in febrile seizures - PMC. [ Online]. [cited 2023 Feb 7]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139179/
   Google Scholar
• Shin G, Kang T-W, Yang S, et al. GENT: gene expression database of normal and tumor tissues. Cancer Inform. 2011;10:149–157. doi:10.4137/CIN.S7226
   PubMedGoogle Scholar
• Fütterer K, Wong J, Grucza RA, et al. Structural basis for Syk tyrosine kinase ubiquity in signal transduction pathways revealed by the crystal structure of its regulatory SH2 domains bound to a dually phosphorylated ITAM peptide. J Mol Biol. 1998 Aug;281(3):523–537. doi: 10.1006/jmbi.1998.1964
   PubMed Web of Science ®Google Scholar
• Mócsai A, Ruland J, Tybulewicz VLJ. The SYK tyrosine kinase: a crucial player in diverse biological functions. Nat Rev Immunol. 2010 Jun;10(6):387–402. doi: 10.1038/nri2765
   PubMed Web of Science ®Google Scholar
• Taniguchi T, Kobayashi T, Kondo J, et al. Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis. J Biol Chem. 1991 Aug;266(24):15790–15796.
   PubMed Web of Science ®Google Scholar
• Wu C, Orozco C, Boyer J, et al. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol. 2009;10(11):R130. doi: 10.1186/gb-2009-10-11-r130
   PubMed Web of Science ®Google Scholar
• Trivedi A, Tercovich KG, Casbon AJ, et al. Neutrophil-specific deletion of Syk results in recruitment-independent stabilization of the barrier and a long-term improvement in cognitive function after traumatic injury to the developing brain. Neurobiol Dis. 2021 Sep;157:105430. doi: 10.1016/j.nbd.2021.105430
   PubMed Web of Science ®Google Scholar
• Kitaura J, Kawakami Y, Maeda-Yamamoto M, et al. Dysregulation of src family kinases in mast cells from epilepsy-resistant ASK versus epilepsy-prone EL Mice1. J Immunol. 2007 Jan;178(1):455–462. doi: 10.4049/jimmunol.178.1.455
   PubMed Web of Science ®Google Scholar
• Strittmatter SM. A Phase Ib multiple ascending dose study of the safety, tolerability, and CNS availability of AZD0530 in Alzheimer’s Disease, clinicaltrials.Gov, Clinical trial registration NCT01864655, Apr 2021. [ Online]. [cited 2023 May 25]. Available from: https://clinicaltrials.gov/ct2/show/NCT01864655
   Google Scholar
• Cancers | free full-text | FAK inhibition induces glioblastoma cell senescence-like state through p62 and p27. [ Online]. [cited 2023 May 5]. Available from: https://www.mdpi.com/2072-6694/12/5/1086
   Google Scholar
• Grabenstatter HL, Del Angel YC, Carlsen J, et al. The effect of STAT3 inhibition on status epilepticus and subsequent spontaneous seizures in the pilocarpine model of acquired epilepsy. Neurobiol Dis. 2014 Feb;62:73–85. doi: 10.1016/j.nbd.2013.09.003
   PubMed Web of Science ®Google Scholar
• Schweig JE, Yao H, Coppola K, et al. Spleen tyrosine kinase (SYK) blocks autophagic Tau degradation in vitro and in vivo. J Biol Chem. 2019 Sep;294(36):13378–13395.
   PubMed Web of Science ®Google Scholar
• Imam SZ, Trickler W, Kimura S, et al. Neuroprotective efficacy of a new brain-penetrating C-Abl inhibitor in a murine Parkinson’s disease model. PLOS ONE. 2013;8(5):e65129. doi: 10.1371/journal.pone.0065129
   PubMed Web of Science ®Google Scholar
• Werner MH, Olanow CW. Parkinson’s disease modification through abl kinase inhibition: an opportunity. Mov Disord. 2022 Jan;37(1):6–15. doi: 10.1002/mds.28858
   PubMed Web of Science ®Google Scholar
• Epilepsy-on-a-chip system for antiepileptic drug discovery - PMC. [ Online]. [cited 2023 Feb 7]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585967/
   Google Scholar
• Sanna PP, Berton F, Cammalleri M, et al. A role for Src kinase in spontaneous epileptiform activity in the CA3 region of the hippocampus. Proc Natl Acad Sci USA. 2000 Jul;97(15):8653–8657. doi: 10.1073/pnas.140219097.
   PubMed Web of Science ®Google Scholar
• Solouki S, August A, Huang W. Non-receptor tyrosine kinase signaling in autoimmunity and therapeutic implications. Pharmacol Ther. 2019 Sep;201:39–50. doi: 10.1016/j.pharmthera.2019.05.008
   PubMed Web of Science ®Google Scholar